Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases. (2023)

First Author: Dündar NB
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s40635-023-00554-y

PubMed Identifier: 37801184

Publication URI: http://europepmc.org/abstract/MED/37801184

Type: Journal Article/Review

Volume: 11

Parent Publication: Intensive care medicine experimental

Issue: 1

ISSN: 2197-425X